Cargando…
Nine-year survival after iterative metastasectomies for renal cell carcinoma
We report the case of a 24-year-old male, diagnosed with an incidental T3a papillary renal cell carcinoma (RCC), treated with left laparoscopic radical nephrectomy. After 7 months, nodal recurrence was identified and retroperitoneal lymph node dissection (RPLND) was performed. Four months later, due...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476217/ https://www.ncbi.nlm.nih.gov/pubmed/31040613 http://dx.doi.org/10.4103/UA.UA_53_18 |
_version_ | 1783412866730164224 |
---|---|
author | de Oliveira, Tiago Ribeiro Ouattara, Adama Everaerts, Wouter De Meerleer, Gert Joniau, Steven |
author_facet | de Oliveira, Tiago Ribeiro Ouattara, Adama Everaerts, Wouter De Meerleer, Gert Joniau, Steven |
author_sort | de Oliveira, Tiago Ribeiro |
collection | PubMed |
description | We report the case of a 24-year-old male, diagnosed with an incidental T3a papillary renal cell carcinoma (RCC), treated with left laparoscopic radical nephrectomy. After 7 months, nodal recurrence was identified and retroperitoneal lymph node dissection (RPLND) was performed. Four months later, due to local recurrence, the patient underwent salvage RPLND, partial psoas resection and left adrenalectomy, and remained without recurrence during the following 15 months, after which treatment with sunitinib was started due to multiple metastases in pelvic lymph nodes, lungs, and bone. After 4 years of stable disease, progression at the quadratus lumborum and psoas muscles led to subsequent metastasectomy. No evidence of progression was identified for 2 years, after which, despite multimodal treatment (axitinib and radiotherapy to bone lesions), widespread disease progression led to patient death. This uncommon case of prolonged survival with metastatic RCC highlights the possible role of iterative metastasectomies in the management of advanced stage disease, as well as its potential to extend the survival substantially, even when progressive on tyrosine kinase inhibitors. |
format | Online Article Text |
id | pubmed-6476217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-64762172019-04-30 Nine-year survival after iterative metastasectomies for renal cell carcinoma de Oliveira, Tiago Ribeiro Ouattara, Adama Everaerts, Wouter De Meerleer, Gert Joniau, Steven Urol Ann Case Report We report the case of a 24-year-old male, diagnosed with an incidental T3a papillary renal cell carcinoma (RCC), treated with left laparoscopic radical nephrectomy. After 7 months, nodal recurrence was identified and retroperitoneal lymph node dissection (RPLND) was performed. Four months later, due to local recurrence, the patient underwent salvage RPLND, partial psoas resection and left adrenalectomy, and remained without recurrence during the following 15 months, after which treatment with sunitinib was started due to multiple metastases in pelvic lymph nodes, lungs, and bone. After 4 years of stable disease, progression at the quadratus lumborum and psoas muscles led to subsequent metastasectomy. No evidence of progression was identified for 2 years, after which, despite multimodal treatment (axitinib and radiotherapy to bone lesions), widespread disease progression led to patient death. This uncommon case of prolonged survival with metastatic RCC highlights the possible role of iterative metastasectomies in the management of advanced stage disease, as well as its potential to extend the survival substantially, even when progressive on tyrosine kinase inhibitors. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6476217/ /pubmed/31040613 http://dx.doi.org/10.4103/UA.UA_53_18 Text en Copyright: © 2019 Urology Annals http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report de Oliveira, Tiago Ribeiro Ouattara, Adama Everaerts, Wouter De Meerleer, Gert Joniau, Steven Nine-year survival after iterative metastasectomies for renal cell carcinoma |
title | Nine-year survival after iterative metastasectomies for renal cell carcinoma |
title_full | Nine-year survival after iterative metastasectomies for renal cell carcinoma |
title_fullStr | Nine-year survival after iterative metastasectomies for renal cell carcinoma |
title_full_unstemmed | Nine-year survival after iterative metastasectomies for renal cell carcinoma |
title_short | Nine-year survival after iterative metastasectomies for renal cell carcinoma |
title_sort | nine-year survival after iterative metastasectomies for renal cell carcinoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476217/ https://www.ncbi.nlm.nih.gov/pubmed/31040613 http://dx.doi.org/10.4103/UA.UA_53_18 |
work_keys_str_mv | AT deoliveiratiagoribeiro nineyearsurvivalafteriterativemetastasectomiesforrenalcellcarcinoma AT ouattaraadama nineyearsurvivalafteriterativemetastasectomiesforrenalcellcarcinoma AT everaertswouter nineyearsurvivalafteriterativemetastasectomiesforrenalcellcarcinoma AT demeerleergert nineyearsurvivalafteriterativemetastasectomiesforrenalcellcarcinoma AT joniausteven nineyearsurvivalafteriterativemetastasectomiesforrenalcellcarcinoma |